SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-20-034828
Filing Date
2020-03-17
Accepted
2020-03-17 17:21:33
Documents
6
Period of Report
2020-05-14

Document Format Files

Seq Description Document Type Size
1 PRE 14A a20-12931_1pre14a.htm PRE 14A 753616
2 GRAPHIC g129311bgi001.jpg GRAPHIC 3445
3 GRAPHIC g129311bci001.jpg GRAPHIC 5431
4 GRAPHIC g129311bci002.jpg GRAPHIC 2352
5 GRAPHIC g129311bci003.jpg GRAPHIC 5344
6 GRAPHIC g129311bci004.gif GRAPHIC 2264
  Complete submission text file 0001104659-20-034828.txt   781371
Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053
Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200
Strongbridge Biopharma plc (Filer) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
Type: PRE 14A | Act: 34 | File No.: 001-37569 | Film No.: 20722082
SIC: 2834 Pharmaceutical Preparations